Risks factors for carnitine depletion include age under 24 months, the presence of concomitant neurologic or metabolic disorders, and receipt of multiple AEDs
Metabolic and endocrine changes, including restoration of menstrual cyclicity or improvement of hyperandrogenism, have also been investigated as secondary outcomes
Crystal structures of Flavobacterium glycosylasparaginase
Varied Results: Effectiveness varies from one individual to another due to genetics, dosage, and formulation (oral, topical, or injectable)
The quality-of-life improvement from sleeping through nausea, if you are someone who experiences significant GI effects, is massive by comparison
In a trial enrolling overweight diabetics, hypoglycemia occurred in 4.2% of tirzepatide-treated patients and 1.3% of placebo-treated patients, with tirzepatide-treated patients taking insulin secretagogues having the greatest risk (10.3%)